Related Business Topics
Latest Headlines
Reuters - Nov. 27, 2009, 7:41 AM
DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/1b2b29/intranasal_drug_de) has announced the addition of the 'Intranasal Drug Delivery - US Market Trends & Analysis' report to their offering. The US intranasal ...
Forbes.com - Nov. 27, 2009, 7:32 AM
BusinessWire - Research and Markets (http://www.researchandmarkets.com/research/1b2b29/intranasal_drug_de) has announced the addition of the 'Intranasal Drug Delivery - US Market Trends & Analysis' report to their offering. The US intranasal drug ...
Forbes.com - Nov. 27, 2009, 4:40 AM
BusinessWire - Research and Markets (http://www.researchandmarkets.com/research/50344c/prostate_cancer_th) has announced the addition of the 'Prostate Cancer Therapeutics - A Global Market Perspective' report to their offering. Growth in prostate cancer ...
Reuters - Nov. 27, 2009, 4:21 AM
DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/50344c/prostate_cancer_th) has announced the addition of the 'Prostate Cancer Therapeutics - A Global Market Perspective' report to their offering. Growth in ...
Forbes.com - Nov. 26, 2009, 7:27 AM
BusinessWire - Research and Markets (http://www.researchandmarkets.com/research/2070d2/osteoporosis_thera) has announced the addition of the 'Osteoporosis Therapeutics - A Global Market Perspective' report to their offering. Osteoporosis, the most ...
Reuters - Nov. 26, 2009, 7:19 AM
DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/2070d2/osteoporosis_thera) has announced the addition of the 'Osteoporosis Therapeutics - A Global Market Perspective' report to their offering. Osteoporosis, the ...
ABC News - Nov. 25, 2009, 9:34 AM
Idera Pharmaceuticals Inc. on Wednesday announced the end of a research partnership with Novartis AG, but said Merck & Co. is extending its work with Idera for another year. Novartis, a Swiss drugmaker, will end its work with Idera on Feb. 21, 2010. The ...
Reuters - Nov. 25, 2009, 6:35 AM
NEW YORK (Reuters) - Incyte Corp (INCY.O) shares jumped 12 percent in premarket trade to $8.64 on Wednesday after the company reached a licensing deal with Swiss drugmaker Novartis AG ...
Reuters - Nov. 25, 2009, 6:01 AM
VANCOUVER, Nov. 25 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX: QLT) ('QLT' or the 'Company') today announced the settlement of its litigation with the General Hospital Corporation, doing business as Massachusetts General Hospital ('MGH'). Under ...
Reuters - Nov. 25, 2009, 6:01 AM
NEW YORK, Nov 25 (Reuters) - Incyte Corp (INCY.O) shares jumped 12 percent in premarket trade to $8.64 on Wednesday after the company reached a licensing deal with Swiss drugmaker Novartis AG (NOVN.VX)(NVS.N), which will pay Incyte $150 million up front ...
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
N
Noven Pharmaceuticals
develops transdermal and transmucosal drug delivery systems, including the estrogen patch and the nation's first combination estrogen/progestin patch.
www.noven.com
develops transdermal and transmucosal drug delivery systems, including the estrogen patch and the nation's first combination estrogen/progestin patch.
www.noven.com
